Abstract:The antitumor efficacy of adoptively transferred T cells is limited by their poor persistence, in part due to exhaustion, but the underlying mechanisms and potential interventions remain underexplored. Here, we show that targeting histone demethylase LSD1 by chemical inhibitors reshapes the epigenome of in vitro activated and expanded CD8+ T cells, and potentiates their antitumor efficacy. Upon T cell receptor activation and IL-2 signaling, a timely and transient inhibition of LSD1 suffices to improve the memory phenotype of mouse CD8+ T cells, associated with a better ability to produce multiple cytokines, resist exhaustion, and persist in both antigen-dependent and -independent manners after adoptive transfer. Consequently, OT1 cells primed with LSD1 inhibitors demonstrate an enhanced antitumor effect in OVA-expressing solid tumor models implanted in female mice, both as a standalone treatment and in combination with PD-1 blockade. Moreover, priming with LSD1 inhibitors promotes polyfunctionality of human CD8+ T cells, and increases the persistence and antitumor efficacy of human CD19-CAR T cells in both leukemia and solid tumor models. Thus, pharmacological inhibition of LSD1 could be exploited to improve adoptive T cell therapy. Phenotypic changes in exhausted T cells are linked to chromatin remodeling. Here the authors show that pharmacological inhibition of the H3K4me1/2 demethylase LSD1 promotes the persistence and enhances the therapeutic activity of adoptively transferred T cells for cancer therapy.

Lsd1 Safeguards T-cell Development Via Suppressing Endogenous Retroelements and Interferon Responses.

Ablation of Lsd1 Induces Viral Mimicry in Thymocytes and Promotes the Development of Innate-Memory T Cells

Priming with LSD1 Inhibitors Promotes the Persistence and Antitumor Effect of Adoptively Transferred T Cells

Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity

Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition

Transcriptional Regulation of Early T-Lymphocyte Development in Thymus

Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte β-selection

Chromatin organizer SATB1 controls the cell identity of CD4+ CD8+ double-positive thymocytes by regulating the activity of super-enhancers

LSD1 drives intestinal epithelial maturation and controls small intestinal immune cell composition independent of microbiota in a murine model

The scaffolding function of LSD1 controls DNA methylation in mouse ESCs

Notch-Induced Endoplasmic Reticulum-Associated Degradation Governs Thymocyte β−Selection

LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade

Histone Demethylase Lsd1 Represses Hematopoietic Stem and Progenitor Cell Signatures During Blood Cell Maturation

LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16.

The Histone Methyltransferase Setd2 is Indispensable for V(D)J Recombination

A Cell-Intrinsic Role for Mst1 in Regulating Thymocyte Egress

CXXC Finger Protein 1 is Critical for T-cell Intrathymic Development Through Regulating H3K4 Trimethylation

LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer

The critical role of LIGHT, a TNF family member, in T cell development.

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells